A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients

A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients

Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung cancer (NSCLC). Erlotinib and gefitinib are the first-generation EGFR-TKIs for patients with NSCLC. However, there is...

Full description

Bibliographic Details
Main Authors: Preenumol Thomas, Bini Vincent, Christeena George, Julie Mariam Joshua, K Pavithran, Meenu Vijayan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Medical Research
Subjects:
Epidermal growth factor receptor inhibitors - erlotinib - gefitinib - non-small cell lung cancer - pharmacoeconomic analysis - treatment response
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2019;volume=150;issue=1;spage=67;epage=72;aulast=Thomas

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2019;volume=150;issue=1;spage=67;epage=72;aulast=Thomas

Similar Items